[1]Patent:US2013/210798,2013,A1,.Locationinpatent:Paragraph0255;0256
[1]JournalofMedicinalChemistry,2005,vol.48,#7,p.2667-2677
[2]Synthesis,2010,#24,p.4287-4299
1381944-27-9
791846-40-7
444582-90-5
174855-57-3
1121596-60-8
78420-25-4 | N2,N5-Dibenzoyl-4-oxo-L-ornithine Methyl Ester | AA00G4NP | MFCD31561950
1119448-03-1 | 3-Methyl-5-(2-methylphenyl)-1,2,4-oxadiazole | AA00HC4L | MFCD13961845
1416980-24-9 | 4-(Bromomethyl)-3-fluorobenzaldehyde | AA00HW35 | MFCD28096625
368866-33-5 | (2S)-2-([(tert-Butoxy)carbonyl]amino)-3-(oxan-4-yl)propanoic acid | AA00I781 | MFCD18252725
878809-77-9 | 4-Amino-2-chloro-6-morpholinopyridine | AA00IEQJ | MFCD24646357
2095504-46-2 | potassium (3-(tert-butoxycarbonyl)-3-azabicyclo[4.1.0]heptan-6-yl)trifluoroborate | AA00IL7Q | MFCD31556359
50712-66-8 | Ethyl 2-(2-methyl-4-nitrophenyl)acetate | AA019FWY | MFCD18396753
1785332-67-3 | 4,4-difluoropyrrolidin-2-one | AA01AUJ0 | MFCD29060257
1015779-45-9 | 3-bromo-5-chloro-1H-pyrazole | AA01CA2K | MFCD22395737
25618-55-7 | 1,2,3-Propanetriol, homopolymer | AA01DQ4B | MFCD01772705
